Pronađeno: 1-5 / 5 radova

Autori: Negroski Donald

>> Filter: Samo Article i Review

Naslov Diroximel fumarate in patients with relapsing-remitting multiple sclerosis: final safety and efficacy results from the phase 3 EVOLVE-MS-1 study (Meeting Abstract)
Autori Singer BA  Drulovic Jelena S  Negroski Donald  Selmaj Krzysztof  Bergh Florian Then  Scaramozza M  Castro-Borrero W  Adair H  Chen Hailu  Levin S  Shankar SL  Wray Sibyl 
Info MULTIPLE SCLEROSIS JOURNAL, (2022), vol. 28 br. 3_SUPPL, Suppl. 3_, str. 625-626
Projekat Biogen
Ispravka ISI/Web of Science   Elečas   Rang časopisa   Citati: ISI/Web of Science  
Naslov Interim Safety and Efficacy Outcomes in Patients With Relapsing-Remitting Multiple Sclerosis who Received Diroximel Fumarate for Up to 2 Years (Meeting Abstract)
Autori Wray Sibyl  Singer Barry A  Drulovic Jelena S  Chen Hailu  Hanna Jerome  Lyons Jennifer  Bergh Florian Then  Kapadia Shivani  Negroski Donald 
Info NEUROLOGY, (2021), vol. 96 br. 15, Suppl. S, str. -
Ispravka ISI/Web of Science   Elečas   Rang časopisa   Citati: ISI/Web of Science  
Naslov Diroximel fumarate in patients with relapsing-remitting multiple sclerosis: interim safety and efficacy results from the Phase 3 EVOLVE-MS-1 Study (Meeting Abstract)
Autori Singer Barry A  Drulovic Jelena S  Chen Hailu  Lyons Jennifer  Then Bergh F  Negroski Donald  Kapadia Sunil 
Info MULTIPLE SCLEROSIS JOURNAL, (2021), vol. 27 br. 2_SUPPL, Suppl. 2_, str. 619-620
Projekat Biogen
Ispravka ISI/Web of Science   Elečas   Rang časopisa   Citati: ISI/Web of Science   Scopus  
Naslov Dimethyl Fumarate to Diroximel Fumarate Switch: Safety and Efficacy Findings from the Phase 3 EVOLVE-MS-1 Study (Meeting Abstract)
Autori Wray Sibyl  Singer BA  Drulovic Jelena S  Lyons J  Bergh Then F  Melikov M  Chen Hailu  Shankar SL  Kapadia Sunil  Negroski Donald 
Info MULTIPLE SCLEROSIS JOURNAL, (2021), vol. 27 br. 1_SUPPL, Suppl. 1_, str. 28-29
Projekat Biogen
Ispravka ISI/Web of Science   Elečas   Rang časopisa   Citati: ISI/Web of Science  
Naslov Diroximel fumarate in patients with relapsing-remitting multiple sclerosis: interim safety and efficacy results from the phase 3 evolve-ms-1 study (Meeting Abstract)
Autori Wray Sibyl  Singer BA  Drulovic Jelena S  Chen Hailu  Hanna J  Lyons J  Bergh Then F  Negroski Donald  Kapadia Sunil 
Info MULTIPLE SCLEROSIS JOURNAL, (2020), vol. 26 br. 3_SUPPL, Suppl. 3_, str. 214-215
Ispravka ISI/Web of Science   Elečas   Rang časopisa   Citati: ISI/Web of Science   Scopus  
Ispis zapisa u formatu:TXT | BibTeX